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Vaccines are an environmentally friendly alternative to acaracides for the control of tick
infestations, to reduce the risk for tick-borne diseases affecting human and animal
health worldwide, and to improve animal welfare and production. Subolesin (SUB,
also known as 4D8) is the functional homolog of Akirin2 involved in the regulation of
development and innate immune response, and a proven protective antigen for the
control of ectoparasite infestations and pathogen infection. Oral vaccination combining
protein antigens with immunostimulants has proven efficacy with increased host welfare
and safety, but has not been used for the control of tick infestations. Here we describe
the efficacy of oral vaccination with a formulation combining Rhipicephalus microplus
SUB and heat inactivatedMycobacterium bovis (IV) on cattle tick infestations and fertility.
The levels of IgG antibody titers against SUB and M. bovis P22, and the expression of
selected immune response genes were determined and analyzed as possible correlates
of protection. We demonstrated that oral immunization with the SUB+IV formulation
resulted in 51% reduction in the number of female ticks and 30% reduction in fertility with
an overall efficacy of 65% in the control of R. microplus infestations by considering the
cumulative effect on reducing tick survival and fertility in cattle. The akr2, IL-1β, and C3
mRNA levels together with antibody levels against SUB correlated with vaccine efficacy.
The effect of the oral immunization with SUB+IV in cattle on tick survival and fertility
is essential to reduce tick infestations, and extended previous results on the effect of
R. microplus SUB for the control of cattle tick infestations. These results support the
development of oral vaccines formulations for the control of tick infestations and the
incidence of tick-borne diseases.
Keywords: subolesin, cattle tick, vaccine, oral vaccination, Rhipicephalus microplus, heat inactivated
Mycobacterium bovis
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INTRODUCTION
Ticks are arthropod vectors of pathogens affecting human
and animal health as well as animal welfare and production
worldwide (Jongejan and Uilenberg, 2004; de la Fuente et al.,
2008; Rashid et al., 2018). The cattle tick Rhipicephalus microplus
Canestrini (Acari: Ixodidae) are economically important as
parasites of a variety of livestock species with an impact
on cattle industry in tropical and subtropical regions of the
world (Rashid et al., 2018).
Despite the use of traditional cattle tick control methods
such as the use of chemical acaricides, habitat management,
and genetic selection of animals with higher resistance to ticks,
tick prevalence continues to be a major economic problem for
the cattle industry (de la Fuente et al., 2017; Rashid et al.,
2018). This persistent problem is due to several factors including
acaracide resistance in ticks and safety issues associated with
these chemicals, which support the development of vaccines as
an effective and environmentally sound approach for the control
of tick infestations (de la Fuente andContreras, 2015; de la Fuente
et al., 2016b; 2017; de la Fuente, 2018). The commercial vaccines
based on the R. microplus BM86 or BM95 recombinant antigens
proved their efficacy for the control of cattle tick infestations and
the reduction in the prevalence of certain tick-borne pathogens
(de la Fuente et al., 2007, 2017; de la Fuente and Contreras, 2015;
Rodríguez-Mallon, 2016; de la Fuente, 2018).
Tick Subolesin (SUB, also known as 4D8) is the functional
ortholog of Akirin2 and is involved in the regulation of different
biological processes including development and innate immune
response (Artigas-Jerónimo et al., 2018). SUB was discovered as
a tick protective antigen (Almazán et al., 2010), and since then it
has shown vaccination efficacy for the control of infestations by
different arthropod ectoparasite species and pathogen infection
and transmission (recently reviewed by de la Fuente and
Contreras, 2015; Artigas-Jerónimo et al., 2018).
Recent advances in tick vaccine research have resulted in the
identification of new protective antigens for the control of tick
infestations (recently reviewed by de la Fuente and Contreras,
2015; de la Fuente et al., 2016b, 2017; de la Fuente, 2018).
However, research aimed at improving tick vaccine efficacy and
safety by combining protective antigens and oral formulations
is still to be done. Oral or intranasal vaccine formulations are
easier to administer, and have proven efficacy with increased
host welfare and safety by reducing stress and the risk of
contamination or infection at the injection site and pathogen
mechanical transmission (Wang et al., 2015; Lawan et al., 2018).
However, orally delivered protein vaccines have a relatively
low immunogenicity and antigen stability after immunization
that require vaccine formulations with selected combinations of
antigens and immunostimulants, and needleless delivery systems
(Fry et al., 2012; Wang et al., 2015). In this context, the
heat inactivated Mycobacterium bovis (IV) has been shown to
activate the innate immune response-mediated trained immunity
through complement component 3 (C3) to reduce mycobacterial
infection and tuberculosis-like lesions in cattle, deer, pig, and
zebrafish orally or systemically vaccinated with IV (Beltrán-
Beck et al., 2014; de la Fuente et al., 2016a; Juste et al., 2016;
Thomas et al., 2017; López et al., 2018, 2019; Risalde et al., 2018).
Therefore, IV appears as a good immunostimulant candidate for
oral vaccine formulations (de la Fuente et al., 2016a).
As a proof of concept of oral tick vaccine formulations,
in this study we orally vaccinated cattle via needleless syringe
using a formulation combining R. microplus SUB with IV for
the control of cattle tick infestation. The results showed an
effect of the oral vaccination on the reduction in the number
of female ticks and fertility. Additionally, the akirin2 (akr2),
interleukin-1beta (IL-1β), and C3 mRNA levels together with
antibody levels against SUB correlated with vaccine efficacy.
These results support research for the development of oral
vaccines formulations for the control of tick infestations and the
incidence of tick-borne diseases.
MATERIALS AND METHODS
Ticks
The R. microplus (Susceptible Media Joya strain, CENAPA,
Mexico) ticks were obtained from a laboratory colonymaintained
at the University of Tamaulipas, Mexico (Merino et al., 2011).
Tick larvae were fed on cross-bred Bos taurus cattle and collected
after repletion to allow for oviposition and hatching in humidity
chambers at 12 h light:12 h dark photoperiod, 22–25◦C and 95%
relative humidity (RH). Larvae were used for infestations at 15
days after hatching from eggs.
Antigen Production and
Vaccine Formulations
The synthetic R. microplus histidine-tag recombinant SUB
(Genbank accession number GQ456170) with optimized codon
usage for Escherichia coli was produced in E. coli BL21
and purified to >95% purity (Figure 1) by Ni affinity
chromatography using 1ml HisTrap FF columns mounted
on an AKTA–FPLC system (GE Healthcare, Piscataway, NJ,
USA) in the presence of 7M urea lysis buffer as previously
described (Almazán et al., 2010; Contreras et al., 2015). Protein
concentration was measured using the Pierce R© BCA protein
assay kit (Thermo Scientific, Rockford, IL, USA).
The IV was prepared from M. bovis field isolate Neiker 1403
(spoligotype SB0339 originally isolated from a naturally infected
wild boar) IV at Neiker-Tecnalia (Derio, Spain) under good
manufacturing practices as previously described (Beltrán-Beck
et al., 2014; Juste et al., 2016; Risalde et al., 2018). Briefly, the
isolate was cultivated for 2–3 weeks inMiddlebrook 7H9medium
enriched with OADC growth supplement (Sigma-Aldrich, St.
Louis, MI, USA), and inactivated in a shaking water bath at
81–83◦C for 40min. The inactivated inoculum was cultured
in BACTEC Mycobacterial Growth Indicator Tubes (Becton
Dickinson; Franklin Lakes, NJ, USA) and onto OADC agar
solidified 7H9 plates in triplicate (100 µl each) to confirm the
absence of viable mycobacteria. The finalM. bovis IV preparation
contained approximately the equivalent of 107 colony forming
units (cfu) in 0.2ml of PBS.
For vaccine formulation, purified recombinant SUB protein
(200µg) was mixed with 6 x 106 cfu IV in 18ml PBS for SUB+IV
group, or the same amount of IV was placed in 18ml PBS
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FIGURE 1 | Experimental design. The antigens used in the study included recombinant R. microplus SUB (>95% purity), heat inactivated M. bovis IV proteins and M.
bovis P22 (as an example, a Coomassie-blue stained SDS-12% polyacrilamide gel is shown with the three antigens and spectra multicolor molecular weight markers
from Thermo Scientific). Cattle were orally vaccinated via needleless syringe on days 0 and 22 using a formulation combining R. microplus SUB antigen with IV as
immunostimulator (SUB+IV group) or IV alone (IV group) for comparative analyses between both groups. After vaccination, cattle were infested with R. microplus
larvae on day 43 for the analysis of vaccine efficacy on the control of tick development and fertility, and the identification of possible correlates of protection and
immune mechanisms based on the host antibody response and the mRNA levels for selected immune response genes.
for control IV group. Vaccine formulations were stored at 4◦C
until used.
Cattle Vaccination and Tick Infestation
Three and two 10-month-old European crossbred calves were
randomly assigned to SUB+IV and IV vaccinated groups.
Vaccines were administered via needleless syringe in the lateral
region of the mouth followed by slightly raising the head of the
calves (Jones et al., 2016). Cattle were vaccinated at days 0 and
22, and then infested at day 43 with 500 R. microplus larvae
in single cells glued on the back of the calves. Adult engorged
female ticks dropping from cattle were daily collected, counted,
and weighted. All the collected adult female ticks were assessed
for oviposition (egg mass weight/tick) and egg fertility (number
of larvae/tick) to calculate vaccine efficacy (E) as previously
reported (Merino et al., 2011, 2013) using only parameters with
significant differences between groups (Table 1). The personnel
vaccinating cattle and collecting the ticks were “blinded” as to
which group animals belonged. Data were analyzed statistically
to compare results between individuals fed on SUB+IV
and IV vaccinated calves by Student’s t-test with unequal
variance (p= 0.05).
Analysis of Cattle IgG Antibody Response
by ELISA
Serum samples were prepared from blood samples collected
from each calf before each immunization (days 0 and 22),














SUB+IV (1) 36 233 ± 92 98 ± 61 592 ± 490
SUB+IV (3) 59 210 ± 68 116 ± 37 961 ± 620
SUB+IV (5) 73 234 ± 47 104 ± 38 819 ± 610
Average ± S.D. 56 ± 19* 226 ± 14 106 ± 9 791 ± 186**
Control IV (2) 113 206 ± 53 114 ± 40 1,118 ± 571
Control IV (4) 116 207 ± 54 114 ± 39 1,157 ± 558
Average ± S.D. 115 ± 2 207 ± 1 114 ± 0 1,138 ± 28
Results are shown for each vaccinated and infested cattle (N = 3 for SUB+IV and N = 2
for IV). Data was analyzed statistically to compare results between ticks fed on SUB+IV
and IV vaccinated cattle (*p = 0.02, **p = 0.04; Student’s t-test with unequal variance).
Vaccine efficacy (E = 65%) was calculated as E = 100 x [1-(DT x DF)], where DT = No.
female ticks in SUB+IV vaccinated calves/female ticks in IV vaccinated calves and DF =
No. larvae/tick in SUB+IV vaccinated calves/No. larvae/tick in IV vaccinated calves.
tick infestation (day 43) and at the end of the experiment
(day 65), and stored at −20◦C until analysis. An indirect
ELISA test was performed to detect IgG antibodies against
R. microplus SUB and M. bovis P22 proteins as described
previously (Merino et al., 2011, 2013; Infantes-Lorenzo et al.,
2018). High absorption capacity polystyrene microtiter plates
were coated with 100 µl (0.01µg/ml solution of purified
recombinant proteins) per well in carbonate-bicarbonate buffer
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(Sigma-Aldrich). After an overnight incubation at 4◦C, coated
plates were blocked with 100 µl/well of blocking solution (5%
skim milk in PBS). Serum samples or PBS as negative control
were diluted (1:1000, 1:5000 and 1:10000, v/v) in blocking
solution and 100 µl/well were added into duplicate wells
of the antigen-coated plates. After an overnight incubation
at 4◦C, the plates were washed three times with a washing
solution (PBS containing 0.05% Tween 20) and then incubated
with 1:20,000 rabbit anti-bovine immunoglubolin G (IgG)–
horseradish peroxidase conjugate (Sigma-Aldrich) for 1 h at
37◦C. After three washes with washing solution, 100 µl/well
of substrate solution (Fast OPD, Sigma-Aldrich) was added.
Finally, the reaction was stopped with 50 µl/well of 2N
H2SO4 and the optical density (OD) was measured in a
spectrophotometer at 450 nm. Antibody titers in SUB+IV
and IV vaccinated cattle were expressed as the O.D450nm
(O.Dcattlesera – O.DPBScontrol) and compared between groups
by ANOVA test (p= 0.05; https://www.socscistatistics.com/tests/
anova/Default2.aspx).
Analysis of Gene Expression by qRT-PCR
Total RNA was extracted from blood samples collected
from each calf before each immunization (days 0 and 22),
tick infestation (day 43) and at the end of the experiment
(day 65) using TRI Reagent BD (Sigma-Aldrich, St. Louis,
MI, USA) following the manufacturer’s instructions. Gene
expression profiles from selected genes involved in immunity
C3 (NM_001040469.2), tumor necrosis factor alpha (TNF-α;
AF348421), IL-1β (NM174093), interleukin 2 (IL-2; NM180997),
akr2 (NM_001110087.1), and interleukin 12 (IL-12; U11815.1)
were analyzed by qRT-PCR using the following gene-specific
forward (F) and reverse (R) 5′- 3′ primers and annealing
temperature (C3, F: ATTGCCAGGTTCTTGTACGG and R:
GTCACTGCCTGATTGCAAGA, 56◦C; TNF-α, F: CCTC
ACCCACACCATCAG, and R: GCGATCTCCCTTCTCCAG,
54◦C; IL-1β , F: TCAGAATGGAAACCCTCTCTC and R:
GCATGGATCAGACAACAGTG, 56◦C; IL-12, F: AAGT
GAAGTCATTGCTGCTG and R: TGTCCATTGAATCCTTG
ATCTC, 54◦C; akr2, F: CATTTATGGGCTGCCTTGTT and
R: TGCACAGCTTCTACCACGAC, 54◦C; IL-12, F: TCTGG
ACACTTCACCTGCTG and R: TGCACAGCTTCTACCA
CGAC, 58◦C) and a Quantitect SYBR Green RT-PCR Kit
in a Rotor Gene Q thermocycler (Qiagen, Inc. Valencia,
CA, USA) following manufacturer’s recommendations. A
dissociation curve was run at the end of the reaction to
ensure that only one amplicon was formed and that the
amplicon denatured consistently in the same temperature range
for every sample (Ririe et al., 1997). The mRNA Ct values
were normalized against Bos taurus ß-actin (AY141970.1, F:
GGCCGAGCGGAAATCG and R: GCCATCTCCTGCTCG
AAGTC, 52◦C) using the genNorm ddCT method (Livak
and Schmittgen, 2001). The normalized mRNA levels (mean
of duplicated and normalized Ct values) were compared
between SUB+IV and IV vaccinated groups by ANOVA
test (p= 0.05; https://www.socscistatistics.com/tests/anova/
Default2.aspx).
Correlation Analysis
Two different Spearman’s Rho correlation analyses (p =
0.05; https://www.socscistatistics.com/tests/spearman/Default2.
aspx) were conducted for the identification of putative correlates
of vaccine efficacy. The analysis was conducted in individual
SUB+IV and IV vaccinated cattle. The first analysis was
conducted between the number of female ticks or larvae/tick
and antibody titers (O.D450nm) or the normalized mRNA levels
at the time of tick infestations (day 43) and at the end of the
experiment (day 65). The second analysis was conducted between
the normalized mRNA levels and antibody titers (O.D450nm)
at the time of tick infestations (day 43) and the end of the
experiment (day 65).
RESULTS AND DISCUSSION
Rationale and Experimental Design
Despite the proven efficacy of R. microplus BM86 and BM95
based vaccines for the control of cattle tick infestations (de la
Fuente et al., 2007, 2017; de la Fuente and Contreras, 2015;
Rodríguez-Mallon, 2016; de la Fuente, 2018) and recent advances
in the identification of new tick protective antigens (de la
Fuente and Contreras, 2015; de la Fuente et al., 2016b, 2017;
de la Fuente, 2018), research is needed for the development
of vaccine formulations with higher efficacy and safety for
the control of tick infestations and tick-borne diseases (de
la Fuente, 2018). To address this challenge, the objective
of this study was to provide a proof of concept for oral
vaccine formulations for the control of cattle tick infestations,
and the identification of candidate correlates of vaccine
efficacy. Oral vaccine formulations are easier to administer
and offer the possibility of reducing stress and vaccination-
associated risks while increasing protective efficacy with effective
immunostimulants (Wang et al., 2015; Lawan et al., 2018).
The experimental design for this study included cattle
vaccination and R. microplus infestations for the analysis of
vaccine efficacy on the control of tick development and fertility
(Figure 1). Cattle were orally vaccinated via needleless syringe
using a formulation combining R. microplus SUB antigen with
proven efficacy in the control of ectoparasite infestations (de
la Fuente and Contreras, 2015; Artigas-Jerónimo et al., 2018)
and IV with immunostimulatory activity (Beltrán-Beck et al.,
2014; de la Fuente et al., 2016a; Juste et al., 2016; Thomas et al.,
2017; López et al., 2018, 2019; Risalde et al., 2018) (SUB+IV
group) or IV alone (IV group) for comparative analyses between
both groups. An untreated group was not included because the
study focused at comparing the effect of the SUB+IV combined
formulation with any background of the IV immunostimulant
alone. The immune markers selected to characterize possible
correlates of vaccine protection included IgG antibodies, which
have been shown to mediate SUB protective response (Merino
et al., 2011, 2013), and the innate immune response-mediated
trained immunity markers akr2, IL-1β, IL-2, IL-12, TNF-α,
and C3 involved in protective response to IV oral or systemic
vaccination in different species (Beltrán-Beck et al., 2014; de la
Fuente et al., 2016a; Juste et al., 2016; Thomas et al., 2017; López
et al., 2018, 2019; Risalde et al., 2018).
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Vaccine Efficacy for the Control of Cattle
Tick Infestations
The results of the vaccination trial showed a 51% reduction in
the number of engorged female ticks obtained in the SUB+IV
group when compared to the IV control (p = 0.02; Table 1).
This reduction in the number of ticks completing feeding was
similar in all three cattle vaccinated with SUB+IV (Table 1).
Additionally and despite animal-to-animal variations, a 30%
reduction in tick fertility was observed in the eggs from ticks
fed on SUB+IV vaccinated calves when compared to the
IV control (p = 0.04; Table 1). The effect of tick vaccines
on the reduction in the number of female ticks completing
feeding and fertility has been identified as a critical parameter
for the control of cattle tick infestations (Schetters et al.,
2016). However, no differences were observed in the weight
of engorged ticks or the oviposition (Table 1), a result that
differs from previous vaccination trials with systemic SUB
(Merino et al., 2011, 2013; Artigas-Jerónimo et al., 2018).
In a previous experiment (Contreras et al., 2015), sera from
pigs orally immunized with SUB, SUB-Major surface protein 1a
(MSP1a) E. coli membrane-bound chimera or PBS as control
were used for R. microplus capillary feeding to evaluate tick
weigh. The results of this preliminary trial showed no effect of
anti-SUB antibodies but a 55% reduction in tick weight increase
after feeding on SUB-MSP1a serum (Contreras et al., 2015).
Bacterial membranes with the surface exposed SUB-MSP1a
chimeric antigen were shown to enhance SUB immunogenicity
and protective capacity, thus providing supporting evidences for
the inclusion of bacterial-derived immunostimulants for SUB-
based oral vaccine formulations (Contreras et al., 2015). The
discrepancies on the effect of vaccination on tick weight may
be attributable to different factors including differences in the
immune response to various SUB antigens and between systemic
and oral vaccine formulations.
Correlates of Vaccine Efficacy and Immune
Mechanisms of Protection
To address the putative protective mechanisms of oral SUB+IV
vaccination in cattle, the IgG antibody response against both SUB
and IV (P22) were first characterized in all animals included in
the study. The antibody response against SUB has been correlated
before with vaccine efficacy in cattle (Merino et al., 2011, 2013).
The P22 antigen is composed by various M. bovis proteins
that have been validated before for the analysis of the antibody
response in IV vaccinated hosts (Infantes-Lorenzo et al., 2017,
2018; López et al., 2018; Risalde et al., 2018).
Despite animal-to-animal differences in the IgG antibody
response to both antigens (Figure 2A), the anti-SUB but
not anti-P22 IgG antibody response was higher in SUB+IV
vaccinated cattle when compared to IV vaccinated group (p =
0.01; Figure 2B). Differences in the animal-to-animal response
could be attributed to variations in vaccine administration via
FIGURE 2 | Effect of oral vaccination and infestation with R. microplus larvae on the cattle IgG antibody response. Serum samples were collected before 1st (day 0)
and 2nd (day 22) immunizations and tick infestation (day 43) with R. microplus larvae, and at the end of the experiment (day 65). (A) IgG antibody titers were
determined by ELISA with serum samples (1:5,000) from individual vaccinated cattle against SUB or P22 proteins. (B) Antibody titers in vaccinated cattle were
expressed as the average + S.D. O.D450nm (O.Dcattlesera – O.DPBScontrol ) and compared between SUB+IV and IV groups by ANOVA test (p < 0.05). (C) The
Spearman’s Rho correlation analyses (p < 0.05) were conducted to correlate the IgG antibody response to SUB or P22 at time of tick infestations (day 43) with the
vaccine effect on tick. The linear correlation coefficients (r) and p-value are shown (N = 5).
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needleless syringe. Furthermore, a correlation analysis between
vaccine efficacy on the reduction in the number of female ticks
and anti-SUB or P22 IgG antibody levels was conducted as one of
the proposed correlates of protection in tick vaccine trials (de la
Fuente and Contreras, 2015). As in previous tick SUB vaccination
trials (Merino et al., 2011, 2013), a negative correlation (r =
−0.9; p = 0.04) was obtained between the number of engorged
female ticks and IgG antibody titers against SUB but not P22
in vaccinated cattle at day 43 (Figure 2C), showing a correlation
between the effect of oral SUB+IV vaccination (IgG antibodies)
and vaccine efficacy on tick development.
The protective mechanism associated with IV vaccination has
been attributed to the activation of the innate immune response-
mediated trained immunity through C3 pathway (Beltrán-Beck
et al., 2014; de la Fuente et al., 2016a; Juste et al., 2016). Therefore,
C3 pathway components and other immune response genes were
selected for the analysis of mRNA levels in vaccinated cattle. The
results showed a tendency toward an increase in mRNA levels
in response to vaccination/infestation in SUB+IV vaccinated
cattle (Figure 3A). In IV-vaccinated cattle, the tendency was
a decrease in mRNA levels at days 22 and 65 following first
vaccination and tick infestation, respectively, and an increase
at day 43 after second vaccination (Figure 3A). Nevertheless,
a positive correlation (r = 0.9; p = 0.04) was obtained only
between TNF-α mRNA levels and IgG antibody titers against
SUB but not P22 at day 43 (Figure 3B). Additionally, for C3
pathway immune response akr2, IL-1β, and C3 genes a negative
correlation (r = −0.9 to −1.0; p = 0.005 to 0.04) was observed
between mRNA levels and the number of engorged female ticks
at day 65 (Figure 4). Finally, TNF-α mRNA levels negatively
correlated (r = −0.9; p = 0.04) with tick fertility (number of
larvae per tick) at day 65 (Figure 4).
Recently, we proposed that the mechanism behind systemic
SUB vaccine protective capacity is based on anti-SUB antibodies
that could enter into tick cells by still unknown mechanisms
where they can interact with cytosolic SUB to prevent its
translocation to the nucleus and/or SUB-protein interactions
necessary to exert its regulatory functions (de la Fuente et al.,
2011) (Figure 4). SUB exerts its function through physical
and/or functional interactions with other proteins that have
not been fully characterized, but include some candidate
proteins involved in the regulation of developmental processes
potentially affecting tick feeding (Artigas-Jerónimo et al., 2018).
Herein, the IgG antibody response against SUB also correlated
with oral vaccination efficacy, therefore suggesting a similar
protective mechanism in orally and systemically vaccinated
cattle (Figure 4).
Considering the negative correlation between anti-SUB IgG
antibody and C3 pathway gene mRNA levels and the number
of female ticks, a protective mechanism for SUB+IV oral
vaccination was proposed (Figure 4). Once the vaccine reaches
the oral mucosa-associated lymphoid tissue underlying the
epithelium, antigen uptake, processing and presentation occurs
viamicrofold/membraneous cells (M) by antigen-presenting cells
FIGURE 3 | Effect of oral vaccination and infestation with R. microplus larvae on the cattle mRNA levels for immune response genes. Blood mRNA was obtained from
samples collected before 1st (day 0) and 2nd (day 22) immunizations and tick infestation (day 43) with R. microplus larvae, and at the end of the experiment (day 65).
(A) The mRNA levels for immune response genes C3, TNF-α, IL-1β, IL-2, akr2, and IL-12 were determined by qRT-PCR in vaccinated cattle, normalized against B.
taurus ß-actin and normalized mRNA levels (mean of duplicated and normalized Ct values) compared between SUB+IV and IV groups by ANOVA test (p < 0.05). (B)
The Spearman’s Rho correlation analyses (p < 0.05; https://www.socscistatistics.com/tests/spearman/Default2.aspx) were conducted to correlate the IgG antibody
response to mRNA levels at time of tick infestations (day 43). The normalized TNF-α mRNA levels were the only that positively correlated with anti-SUB but not P22
IgG antibody levels. The linear correlation coefficients (r) and p-value are shown (N = 5).
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FIGURE 4 | Proposed mechanism of protection for oral SUB+IV vaccine against tick infestations in cattle. Based on the negative correlation between anti-SUB IgG
antibody and C3 pathway gene mRNA levels and the number of female ticks, a protective mechanism for SUB+IV oral vaccination was proposed. After the vaccine
reaches the oral mucosa-associated lymphoid tissue underlying the epithelium, antigen uptake, processing, and presentation occurs via microfold/membraneous cells
(M) by antigen-presenting cells (APCs) such as macrophages (Mφ), dendritic cells (DCs) and B cells (B). The C3 pathway activated in DCs and other cell types bridge
the innate and adaptive immune systems for the initiation of antigen-specific response by activated T cells (T), T helper cells (Th), cytotoxic T lymphocytes (CTLs) and
B cells. Activated adaptive immune response cells secrete cytokines such as IL-12, IL-2, and TNF-α to realize the systemic immune protection. The C3 pathway was
activated after oral vaccination with SUB+IV to mediate the production of IgG antibodies affecting SUB translocation/function after ingestion with blood meal for the
reduction of tick infestations.
(APCs) such as macrophages (Mφ), dendritic cells (DCs) and
B cells (B) (Wang et al., 2015) (Figure 4). The key APCs,
DCs bridge the innate and adaptive immune systems for the
initiation of antigen-specific response by activated T cells (T),
T helper cells (Th), cytotoxic T lymphocytes (CTLs) and B cells
(Holmgren and Czerkinsky, 2005; Peng et al., 2006; Lawson
et al., 2011; Wang et al., 2015) (Figure 4). The C3 pathway
mediates bridging of the innate and adaptive immune responses
(Lubbers et al., 2017) (Figure 4). Activated adaptive immune
response cells secrete cytokines such as IL-12, IL-2, and TNF-α,
which mRNA levels positively correlated with anti-SUB antibody
titers (Figure 3B), and then migrate to and multiply through
the common mucosal immune system to realize the systemic
immune protection (Seder and Hill, 2000; Wang et al., 2015).
As also shown in this study, the production of neutralizing
antibodies is vital for protective humoral immune response in
reducing tick infestations (de la Fuente et al., 1998, 2011; Merino
et al., 2011, 2013; Contreras and de la Fuente, 2016, 2017).
In this process, the C3 pathway that was activated after oral
vaccination with SUB+IV has been shown to mediate antibody
response (Rutemark et al., 2011), a finding supported here by
the positive correlation between akr2, IL-1β, and C3 mRNA
levels and the number of female ticks (Figure 4). Additionally,
the proinflammatory cytokine IL-1β has been reported to
induce antigen-specific serum IgG and lymphocyte proliferative
responses with intranasally administered with soluble protein
antigens (Staats and Ennis, 1999).
Finally, the negative correlation between TNF-α mRNA levels
and the number of larvae per tick suggested that T-mediated
response after SUB+IV oral vaccination may have a role in the
reduction of tick fertility. As discussed above and supported in
this study, antigen-specific IgG antibody response plays a key role
in the protective response to tick vaccines (de la Fuente et al.,
1998, 2011; Merino et al., 2011, 2013; Contreras and de la Fuente,
2016, 2017). However, the possible role of the complement,
T immune response and other effector mechanisms has been
considered before as part of tick vaccine efficacy (Tellam et al.,
1992). The development of specific antibody- or T-mediated
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immunologic responses and the activation of mucosally-induced
immunity depend on complex sets of immunologic events,
including the antigen-induced activation of different populations
of B, T, and APC, and the expression of proinflammatory and
immunoregulatory cytokines (Dinarello, 2000; Ogra et al., 2001).
In particular, the proinflammatory cytokine TNF-α has been
associated with DC maturation in mucosal immune response
(Ogra et al., 2001). The results obtained here suggested that future
experiments should address this component of the protective
immune response to both systemic and oral vaccination with
tick antigens. Additionally, other events and cytokines such
as IL-4, IL-5, IL-6, IL-10, colony-stimulating factor (CSF),
interferon gamma (IFN-γ) and transforming growth factor
beta (TGF-β) reported to be involved in mucosal immune
responses together with variations in APC, B, and T cell subsets
should be addressed to provide additional support for the
proposed protective mechanisms elicited by oral vaccination
with SUB+IV.
CONCLUSIONS
The results of this study confirmed the efficacy of tick SUB for
the control of cattle tick infestations, and expanded these results
to oral vaccination with this antigen in combination with the IV
immunostimulant. Furthermore, the identification of correlates
of oral SUB+IV vaccine protection provided markers and targets
for future experiments with larger number of animals aimed
at conducting analyses to provide additional support for the
protective immune mechanisms, the duration of the protective
response, and optimizing vaccine formulation, delivery and
efficacy. An optimal oral vaccine formulation requires the
appropriate combination of antigens, immunostimulants and
delivery carriers to induce a series of protective immune
responses as shown here by the activation of the C3 pathway
and the production of IgG antibodies and relevant cytokines
(Figure 4). Research focused on oral tick vaccines would have a
positive impact on the control of tick infestations and tick-borne
diseases in humans, farm and companion animals through
reducing stress and systemic vaccination-associated risks while
increasing protective efficacy.
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